IL117035A - Paroxetine hydrochloride anhydrate substantially free of bound propan-2-ol processes for its preparation and pharmaceutical compositions containing it - Google Patents
Paroxetine hydrochloride anhydrate substantially free of bound propan-2-ol processes for its preparation and pharmaceutical compositions containing itInfo
- Publication number
- IL117035A IL117035A IL11703596A IL11703596A IL117035A IL 117035 A IL117035 A IL 117035A IL 11703596 A IL11703596 A IL 11703596A IL 11703596 A IL11703596 A IL 11703596A IL 117035 A IL117035 A IL 117035A
- Authority
- IL
- Israel
- Prior art keywords
- processes
- preparation
- pharmaceutical compositions
- substantially free
- compositions containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9502297.6A GB9502297D0 (en) | 1995-02-06 | 1995-02-06 | Novel compound |
GBGB9503112.6A GB9503112D0 (en) | 1995-02-17 | 1995-02-17 | Novel compound |
GBGB9509807.5A GB9509807D0 (en) | 1995-05-15 | 1995-05-15 | Novel compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
IL117035A0 IL117035A0 (en) | 1996-09-12 |
IL117035A true IL117035A (en) | 2000-02-29 |
Family
ID=27267578
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL11703596A IL117035A (en) | 1995-02-06 | 1996-02-05 | Paroxetine hydrochloride anhydrate substantially free of bound propan-2-ol processes for its preparation and pharmaceutical compositions containing it |
Country Status (47)
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3882224B2 (ja) | 1996-05-31 | 2007-02-14 | 旭硝子株式会社 | パロキセチンの製造方法 |
EP0812827B1 (en) | 1996-06-13 | 2009-09-02 | Sumitomo Chemical Company, Limited | Piperidine derivative as intermediates for the preparation of paroxetine and process for their preparation |
WO1998002556A2 (en) * | 1996-07-15 | 1998-01-22 | Smithkline Beecham Plc | Screening for and use of an esterase for a stereospecific resolution |
US6638948B1 (en) | 1996-09-09 | 2003-10-28 | Pentech Pharmaceuticals, Inc. | Amorphous paroxetine composition |
US5672612A (en) * | 1996-09-09 | 1997-09-30 | Pentech Pharmaceuticals, Inc. | Amorphous paroxetine composition |
CA2193939C (en) * | 1996-12-24 | 2002-02-12 | K.S. Keshava Murthy | Useful form of anhydrous paroxetine hydrochloride |
WO1998056787A1 (en) * | 1997-06-10 | 1998-12-17 | Synthon B.V. | 4-Phenylpiperidine compounds |
EP0903345B1 (de) * | 1997-08-08 | 2000-10-04 | Aventis Pharma Deutschland GmbH | Kristallform von 5-Methylisoxazol-4-carbonsäure-(4-trifluormethyl)-anilid |
GB9726907D0 (en) * | 1997-12-19 | 1998-02-18 | Smithkline Beecham Plc | Novel compounds |
PL342931A1 (en) * | 1998-03-16 | 2001-07-16 | Smithkline Beecham Plc | Crystalline form of paroxetine |
GB9806312D0 (en) * | 1998-03-24 | 1998-05-20 | Smithkline Beecham Plc | Novel formulations |
AU2003200534B2 (en) * | 1998-03-24 | 2004-12-02 | Smithkline Beecham Plc | Paroxetine compositions |
US6699882B2 (en) | 1998-03-24 | 2004-03-02 | Smithkline Beecham P.L.C. | Paroxetine compositions |
JP3796351B2 (ja) * | 1998-04-13 | 2006-07-12 | 住友化学株式会社 | パロキセチン塩酸塩無水和物の乾燥方法 |
GB9812941D0 (en) * | 1998-06-16 | 1998-08-12 | Smithkline Beecham Plc | Method of treatment |
CH689805A8 (fr) * | 1998-07-02 | 2000-02-29 | Smithkline Beecham Plc | Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant. |
ES2138937B1 (es) | 1998-07-07 | 2000-10-01 | Medichem Sa | Polimorfo de maleato de paroxetina y formulaciones farmaceuticas que lo contienen. |
JP2002522434A (ja) * | 1998-08-07 | 2002-07-23 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | 非結晶性無水形のパロキセチン塩酸塩の製法 |
GB9824298D0 (en) * | 1998-11-05 | 1998-12-30 | Smithkline Beecham Plc | Novel process |
GB9826175D0 (en) * | 1998-11-28 | 1999-01-20 | Smithkline Beecham Plc | Novel process |
GB9826176D0 (en) * | 1998-11-28 | 1999-01-20 | Smithkline Beecham Plc | Novel process |
GB9826178D0 (en) * | 1998-11-30 | 1999-01-20 | Smithkline Beecham Plc | Novel process |
GB9826180D0 (en) * | 1998-11-30 | 1999-01-20 | Smithkline Beecham Plc | Novel process |
EP1408039A3 (en) * | 1998-11-30 | 2004-05-12 | Smithkline Beecham Plc | Mixed paroxetine propan-2-ol solvates |
GB9826242D0 (en) * | 1998-11-30 | 1999-01-20 | Smithkline Beecham Plc | Novel process |
GB9826171D0 (en) * | 1998-11-30 | 1999-01-20 | Smithkline Beecham Plc | Novel compounds |
GB9828767D0 (en) * | 1998-12-29 | 1999-02-17 | Smithkline Beecham Plc | Novel process |
JP4854115B2 (ja) * | 1999-03-12 | 2012-01-18 | エイシカ ファーマシューティカルス リミテッド | 無水パロキセチン用安定製剤形 |
GB9914585D0 (en) * | 1999-06-22 | 1999-08-25 | Smithkline Beecham Plc | Novel process |
GB9914583D0 (en) * | 1999-06-22 | 1999-08-25 | Smithkline Beecham Plc | Novel process |
GB9919001D0 (en) * | 1999-08-12 | 1999-10-13 | Smithkline Beecham Plc | Novel process |
GB9923439D0 (en) * | 1999-10-04 | 1999-12-08 | Smithkline Beecham Plc | Novel process |
GB9923445D0 (en) * | 1999-10-04 | 1999-12-08 | Smithkline Beecham Plc | Novel process |
GB9923446D0 (en) * | 1999-10-04 | 1999-12-08 | Smithkline Beecham Plc | Novel process |
HU226912B1 (en) * | 2000-04-07 | 2010-03-01 | Richter Gedeon Nyrt | New paroxetin salt and medicament containing it |
JPWO2002022609A1 (ja) * | 2000-09-14 | 2004-01-22 | 旭硝子株式会社 | 実質的に有機溶媒を含まないパロキセチン塩類の製造方法 |
JP2005524656A (ja) * | 2002-02-22 | 2005-08-18 | テバ ファーマシューティカル インダストリーズ リミティド | 新規中間物質を用いるパロキセチンの調製 |
WO2007062147A1 (en) * | 2005-11-22 | 2007-05-31 | Teva Pharmaceutical Industries Ltd. | Crystal forms of cinacalcet hci and processes for their preparation |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1422263A (en) * | 1973-01-30 | 1976-01-21 | Ferrosan As | 4-phenyl-piperidine compounds |
GB8430581D0 (en) * | 1984-12-04 | 1985-01-09 | Ferrosan As | Treatment |
EP0223403B1 (en) * | 1985-10-25 | 1993-08-04 | Beecham Group Plc | Piperidine derivative, its preparation, and its use as medicament |
GB8626936D0 (en) * | 1986-11-11 | 1986-12-10 | Ferrosan As | Treatment |
DK716088D0 (da) * | 1988-12-22 | 1988-12-22 | Ferrosan As | Reduktion af piperidin-dion-derivater samt intermediat |
DK715988D0 (da) * | 1988-12-22 | 1988-12-22 | Ferrosan As | Etherifikation og dealkylering af piperidin-derivater samt intermediater |
EP0558679A1 (en) * | 1990-11-24 | 1993-09-08 | BEECHAM GROUP plc | Use of paroxetine for the treatment of senile dementia, bulimia, migraine or anorexia |
GB9325644D0 (en) * | 1993-12-15 | 1994-02-16 | Smithkline Beecham Plc | Novel formulation |
-
1996
- 1996-02-01 AR ARP960101230A patent/AR001982A1/es not_active Application Discontinuation
- 1996-02-01 SK SK143-96A patent/SK283608B6/sk not_active IP Right Cessation
- 1996-02-02 BR BR9600534A patent/BR9600534A/pt not_active IP Right Cessation
- 1996-02-02 EP EP96903970A patent/EP0808314B1/en not_active Expired - Lifetime
- 1996-02-02 LV LVP-96-31A patent/LV11618B/en unknown
- 1996-02-02 DE DE69621777T patent/DE69621777T2/de not_active Expired - Lifetime
- 1996-02-02 MC MC2329A patent/MC2411A1/xx unknown
- 1996-02-02 AU AU43328/96A patent/AU701518C/en not_active Ceased
- 1996-02-02 WO PCT/EP1996/000447 patent/WO1996024595A1/en active IP Right Grant
- 1996-02-02 CZ CZ0032096A patent/CZ297171B6/cs not_active IP Right Cessation
- 1996-02-02 MY MYPI96000383A patent/MY132529A/en unknown
- 1996-02-02 EP EP03078024A patent/EP1378508A1/en not_active Withdrawn
- 1996-02-02 FR FR9601297A patent/FR2730232B1/fr not_active Expired - Fee Related
- 1996-02-02 DE DE19603797A patent/DE19603797C2/de not_active Revoked
- 1996-02-02 IE IE960104A patent/IE80500B1/en not_active IP Right Cessation
- 1996-02-02 DE DE1996631298 patent/DE69631298T2/de not_active Expired - Lifetime
- 1996-02-02 AU AU47864/96A patent/AU4786496A/en not_active Abandoned
- 1996-02-02 EP EP01115079A patent/EP1136490B1/en not_active Expired - Lifetime
- 1996-02-02 MX MX9600484A patent/MX9600484A/es not_active IP Right Cessation
- 1996-02-02 RO RO96-00183A patent/RO112426B1/ro unknown
- 1996-02-03 KR KR1019960002620A patent/KR100289885B1/ko not_active IP Right Cessation
- 1996-02-03 SG SG1996000861A patent/SG43787A1/en unknown
- 1996-02-04 DZ DZ960030A patent/DZ1989A1/fr active
- 1996-02-05 CA CA002210023A patent/CA2210023C/en not_active Expired - Fee Related
- 1996-02-05 PL PL96312646A patent/PL189247B1/pl unknown
- 1996-02-05 LU LU88711A patent/LU88711A1/fr unknown
- 1996-02-05 SE SE9600406A patent/SE521084C2/sv not_active IP Right Cessation
- 1996-02-05 JP JP8018679A patent/JP2915338B2/ja not_active Expired - Fee Related
- 1996-02-05 UA UA96020442A patent/UA49796C2/uk unknown
- 1996-02-05 ES ES09600262A patent/ES2114471B1/es not_active Expired - Fee Related
- 1996-02-05 RU RU96102180A patent/RU2125052C1/ru not_active IP Right Cessation
- 1996-02-05 FI FI960519A patent/FI111544B/sv not_active IP Right Cessation
- 1996-02-05 GR GR960100038A patent/GR1002466B/el not_active IP Right Cessation
- 1996-02-05 CN CNB2004100855519A patent/CN1289496C/zh not_active Expired - Fee Related
- 1996-02-05 CA CA002168829A patent/CA2168829C/en not_active Expired - Fee Related
- 1996-02-05 DK DK011996A patent/DK11996A/da not_active Application Discontinuation
- 1996-02-05 IL IL11703596A patent/IL117035A/xx unknown
- 1996-02-05 CN CN96103526A patent/CN1090187C/zh not_active Expired - Fee Related
- 1996-02-05 CA CA002210022A patent/CA2210022C/en not_active Expired - Fee Related
- 1996-02-05 HU HU9600255A patent/HUP9600255A1/hu unknown
- 1996-02-05 MA MA24157A patent/MA23802A1/fr unknown
- 1996-02-05 NZ NZ280943A patent/NZ280943A/en not_active IP Right Cessation
- 1996-02-05 NL NL1002248A patent/NL1002248C2/xx not_active IP Right Cessation
- 1996-02-05 SI SI9600378A patent/SI21923B/sl not_active IP Right Cessation
- 1996-02-05 BG BG100333A patent/BG62967B1/bg unknown
- 1996-02-05 IT IT96MI000203A patent/IT1289532B1/it active IP Right Grant
- 1996-02-05 AT AT0021096A patent/AT407528B/de not_active IP Right Cessation
- 1996-02-05 CA CA002211522A patent/CA2211522C/en not_active Expired - Fee Related
- 1996-02-05 BE BE9600101A patent/BE1009112A3/fr not_active IP Right Cessation
- 1996-02-05 TW TW085101374A patent/TW503238B/zh not_active IP Right Cessation
- 1996-02-05 SI SI9600036A patent/SI9600036B/sl not_active IP Right Cessation
- 1996-02-05 NO NO960472A patent/NO301009B1/no not_active IP Right Cessation
- 1996-02-06 TR TR96/00096A patent/TR199600096A2/xx unknown
- 1996-02-06 OA OA60773A patent/OA10261A/en unknown
- 1996-02-06 PT PT101827A patent/PT101827B/pt not_active IP Right Cessation
- 1996-02-06 CH CH01510/97A patent/CH689229A5/de not_active IP Right Cessation
- 1996-02-06 CH CH00304/96A patent/CH688353A5/de not_active IP Right Cessation
- 1996-02-06 CH CH02051/98A patent/CH689804A5/de not_active IP Right Cessation
-
1997
- 1997-02-28 NO NO19970939A patent/NO311519B1/no not_active IP Right Cessation
- 1997-05-08 HK HK59397A patent/HK59397A/xx not_active IP Right Cessation
-
1998
- 1998-12-02 JP JP10342812A patent/JPH11228571A/ja active Pending
-
2000
- 2000-08-31 CN CN001268872A patent/CN1216055C/zh not_active Expired - Fee Related
-
2001
- 2001-02-12 DK DKPA200100223 patent/DK200100223A/da not_active Application Discontinuation
- 2001-10-18 NO NO20015070A patent/NO20015070D0/no not_active Application Discontinuation
-
2002
- 2002-10-18 AR ARP020103931A patent/AR036856A2/es unknown
-
2003
- 2003-02-03 FI FI20030162A patent/FI20030162A/sv unknown
- 2003-03-12 FI FI20030370A patent/FI20030370A/sv not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL117035A (en) | Paroxetine hydrochloride anhydrate substantially free of bound propan-2-ol processes for its preparation and pharmaceutical compositions containing it | |
ZA968907B (en) | Compositions and methods for buccal delivery of pharmaceutical agents | |
HUP9701281A3 (en) | Piperidine derivatives as neurokinin antagonists and pharmaceutical compositions containing them | |
PL351492A1 (en) | Novel polymorphic forms of an antidiabetic agent: process for their preparation and pharmaceutical compositions containing them | |
HUP0002183A3 (en) | Pharmaceutical composition for combination of piperidinoalkanol-decongestant | |
HUP9900467A3 (en) | Novel acid-labile pharmaceutical composition containing omeprazole and process for its preparation | |
IL116486A0 (en) | Novel piperidine derivatives processes for their preparation and pharmaceutical compositions containing them | |
AP2001002270A0 (en) | Metalloproteinaise inhibitors pharmaceutical compositions containing them and their pharmaceeutical uses and methods and intermediates useful for their preparation | |
ZA969001B (en) | Method compositions and kits for increasing the oral bioavailability of pharmaceutical agents | |
SI0807111T1 (en) | Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same | |
IL116917A (en) | Piperidine derivatives and pharmaceutical compositions containing them | |
IL122118A0 (en) | Crystalline form I atorvastatin pharmaceutical compositions containing it and process for its preparation | |
IL119647A0 (en) | Crystalline hydrochloride of (R)-(-)-2-[N-[4-(1,I-dioxido- 3-oxo-2,3-dihydro-benzisothiazol-2-yl)-butyl]-aminomethyl]-chroman its preparation and a pharmaceutical composition containing it | |
IL117810A0 (en) | N-substituted azaheterocyclic carboxylic compounds their preparation and pharmaceutical compositions containing them | |
HUP0004008A3 (en) | Polymorphic form of a morpholine derivative having tachykinin receptor antagonist activity and pharmaceutical compositions containing the same | |
IL115771A (en) | Apolipoprotein-B synthesis inhibitors their preparation and pharmaceutical compositions containing them | |
HUP0003198A2 (en) | Thermodynamically stable modification of 1-(4-carbazoly-loxy)-3-[2-(2-(methoxyphenoxy)ethylamino]-2-propanole, process for its preparation and pharmaceutical compositions containing it | |
IL115324A0 (en) | Neurokinin antagonist compounds their preparation and pharmaceutical compositions containing them | |
GB9710800D0 (en) | Pharmaceutical composition and method of preparing it | |
HUP0000960A3 (en) | Spray-dried paroxetine hydrochloride, process for it's preparation,use of the compound and pharmaceutical compositions containing the same | |
IL116539A0 (en) | Compositions for transdermal delivery of acid-labile drugs | |
EG23781A (en) | Pharmaceutical composition containing tiagabine hydrochloride and the process for its preparation | |
HUP9800970A3 (en) | Process for producing pharmaceutical compositions containing heptapeptide somatostatin derivatives of neurogene- and non-neurogene-antiflogistic and analgesic activity and peptidomimetica | |
HUP0103134A3 (en) | Process for preparation crystalline forms of osanetant and pharmaceutical compositions containing them | |
HUP0100019A3 (en) | Novel polymorphic forms of cipamfylline, process for their preparation and pharmaceutical compositions thereof |